Category: ID Guide

Candidal Endocarditis – Looking for Sasquash

Infective endocarditis is a rare enough disease in and of itself that many folks won’t see much of in their lifetimes, though the rise in IV drug abuse means this may not be the case in the future. Staphylococcus aureus and streptococci, as well as enterococci, tend to be the most common organisms associated with

Continue reading

Hyperammonemia Syndrome – Ureaplasma and Mycoplasma spp Infections

Hyperammonemia is the accumulation of ammonia within the blood that leads to cerebral edema, herniation, and death in patients with inborn errors of metabolism and hepatic failure. These are the types of patients where we would commonly see such accumulation of ammonia. In absence of liver failure, inborn errors of metabolism, urea cycle disorders, or

Continue reading

Tracking Disseminated Histoplasmosis Treatment

When I say bat poop, caves, and Indiana, the answer is Histoplasmosis. In general, most people will not get disease even when inhaling any conidia, however those who have decreased cellular immunity (i.e. solid organ transplant and HIV) are at risk of pulmonary or disseminated disease. One of the difficult issues in those patients is

Continue reading

Actinomycoses Infections

Unlike some of my previous recent posts (read: Leishmania, Hantavirus), I think this one is of value. The reason being this bug is not thought of (outside of medical school, when it is learned with Nocardia). Most of the time, this infection is diagnosed by the pathologist, after a surgery to remove what is thought

Continue reading

The Nephrotoxicity of Piperacillin-Tazobactam

Depending on where you practice, I think it is safe to assume there is a “nickname” for the combination of vancomycin/piperacillin-tazobactam (VAN/PTZ). “Guerilla-cillin,” “Parkla-mycin” or just “the big guns” this is a very common combination that is thrown up front for sepsis or health-care acquired infections (the debate of whether this is an appropriate approach

Continue reading

The Shift in the Treatment of Native Valve Enterococcal Endocarditis

A 72yo male with history of hypertension, kidney stones, and recent diagnosis of acute prostatitis presents with malaise and myalgias. According to the patient, he has been feeling unwell for the past month. He had a recent outpatient visit for dysuria, the UA was positive for leukocyte esterase. A DRE revealed acute prostatitis and he

Continue reading

When To Get A TEE for Staphylococcus Aureus Bacteremia

Staphylococcus aureus bacteremia is a cause of severe morbidity and mortality, especially when it is complicated by infective endocarditis. The mortality of Staphylococcus aureus bacteremia is 20% (1) and that of infective endocarditis due to Staph aureus is much higher. Guidelines for the treatment of MRSA SAB (2) recommends the use of echocardiography, with TEE

Continue reading

A Crash Course of Beta-Lactamases and Beta-Lactamase Inhibitors

Beta-Lactamases make my head hurt. They are so many of them and they impact the therapeutic options for a lot of the infections that we treat. Due to this resistance mechanism, there has been an influx of new beta-lactam/beta-lactamase combinations (ceftazidime-avibactam, meropenem-vaborbactam, etc) to overcome this phenomena. So first, this is a beta-lactam: The penicillin-binding

Continue reading